国偷自产一区二区三区在线观看-年下总裁被打光屁股sp-久久强奷乱码老熟女网站-国产精品久久久久aaaa樱花-韩国av电影一区二区三区-欧美 日韩 一区二区 国产-91看片淫黄大片一级在线观看-白嫩嫩翘臀美女在线视频-精品无区av一区二区二区不卡-国产在线天堂-在线一区二区不卡播放

歡迎來到北京博奧森生物技術(shù)有限公司網(wǎng)站!
咨詢熱線

18611424007

當(dāng)前位置:首頁  >  產(chǎn)品中心  >  抗體/抗原  >  標(biāo)記一抗

  • bs-1973R-FITCFITC標(biāo)記的脂蛋白脂酶抗體

    Lipoprotein lipase (LPL) is the central enzyme in plasma triglyceride hydrolysis and is secreted by macrophages in the subendothelial space. Evidence has been provided that LPL produced by macrophages in the vessel wall exerts proatherogenic effects. The atherogenic effects of LPL have been mainly attributed to its ability to favor lipid accumulation within macrophages present in the atherosclerotic lesion. Recently, it has also been shown that LPL promote the development of atherosclerosis th

    更新時(shí)間:2025-03-09
    型號(hào):bs-1973R-FITC
    廠商性質(zhì):生產(chǎn)廠家
    瀏覽量:391
  • bs-1973R-BioBiotin標(biāo)記的脂蛋白脂酶抗體

    Lipoprotein lipase (LPL) is the central enzyme in plasma triglyceride hydrolysis and is secreted by macrophages in the subendothelial space. Evidence has been provided that LPL produced by macrophages in the vessel wall exerts proatherogenic effects. The atherogenic effects of LPL have been mainly attributed to its ability to favor lipid accumulation within macrophages present in the atherosclerotic lesion. Recently, it has also been shown that LPL promote the development of atherosclerosis th

    更新時(shí)間:2025-03-09
    型號(hào):bs-1973R-Bio
    廠商性質(zhì):生產(chǎn)廠家
    瀏覽量:413
  • bs-2708R-PEPE標(biāo)記的信號(hào)調(diào)節(jié)蛋白α抗體

    Protein tyrosine phosphatases (PTPases) SHP1 and SHP2 are critical regulators in the intracellular signaling pathways that result in cell responses such as mitosis, differentiation, migration, survival, transformation or death. SHP2 is a signal transducer for several receptor tyrosine kinases and cytokine receptors. A novel SHP2 associated glycoprotein was recently cloned from human, rat, mouse and cattle by several labs and was designated SIRPa (1),SHPS1 , MyD1, BIT and p84. SIRPa is a ne

    更新時(shí)間:2025-03-09
    型號(hào):bs-2708R-PE
    廠商性質(zhì):生產(chǎn)廠家
    瀏覽量:422
  • bs-2708R-Cy5Cy5標(biāo)記的信號(hào)調(diào)節(jié)蛋白α抗體

    Protein tyrosine phosphatases (PTPases) SHP1 and SHP2 are critical regulators in the intracellular signaling pathways that result in cell responses such as mitosis, differentiation, migration, survival, transformation or death. SHP2 is a signal transducer for several receptor tyrosine kinases and cytokine receptors. A novel SHP2 associated glycoprotein was recently cloned from human, rat, mouse and cattle by several labs and was designated SIRPa (1),SHPS1 , MyD1, BIT and p84. SIRPa is a ne

    更新時(shí)間:2025-03-09
    型號(hào):bs-2708R-Cy5
    廠商性質(zhì):生產(chǎn)廠家
    瀏覽量:404
  • bs-2708R-HRPHRP標(biāo)記的信號(hào)調(diào)節(jié)蛋白α抗體

    Protein tyrosine phosphatases (PTPases) SHP1 and SHP2 are critical regulators in the intracellular signaling pathways that result in cell responses such as mitosis, differentiation, migration, survival, transformation or death. SHP2 is a signal transducer for several receptor tyrosine kinases and cytokine receptors. A novel SHP2 associated glycoprotein was recently cloned from human, rat, mouse and cattle by several labs and was designated SIRPa (1),SHPS1 , MyD1, BIT and p84. SIRPa is a ne

    更新時(shí)間:2025-03-09
    型號(hào):bs-2708R-HRP
    廠商性質(zhì):生產(chǎn)廠家
    瀏覽量:430
  • bs-2708R-BioBiotin標(biāo)記的信號(hào)調(diào)節(jié)蛋白α抗體

    Protein tyrosine phosphatases (PTPases) SHP1 and SHP2 are critical regulators in the intracellular signaling pathways that result in cell responses such as mitosis, differentiation, migration, survival, transformation or death. SHP2 is a signal transducer for several receptor tyrosine kinases and cytokine receptors. A novel SHP2 associated glycoprotein was recently cloned from human, rat, mouse and cattle by several labs and was designated SIRPa (1),SHPS1 , MyD1, BIT and p84. SIRPa is a ne

    更新時(shí)間:2025-03-09
    型號(hào):bs-2708R-Bio
    廠商性質(zhì):生產(chǎn)廠家
    瀏覽量:407
共 2217 條記錄,當(dāng)前 93 / 370 頁  首頁  上一頁  下一頁  末頁  跳轉(zhuǎn)到第頁